# Pharma Phorum * **Definition:** Pharma Phorum is an online platform that provides news, analysis, and insights related to the pharmaceutical industry, focusing on trends, regulatory updates, and market developments. * **Taxonomy:** Key Sources / Healthcare Publications / Pharma Phorum ## News * Selected news from the source **Pharma Phorum**, for healthcare technology leaders * 1.4K news items are in the system for this source * Posts have been filtered for tech-related keywords | Date | Title | Topics | | --- | --- | --- | | 12/6/2024 | [**Atlas closes $450m biotech fund, and other financing news**](https://pharmaphorum.com/news/atlas-closes-450m-biotech-fund-and-other-financing-news) | [[Gene Therapies]]; [[AI in Medicine]]; [[Diversity in Clinical Trials]] | | 9/30/2024 | [**Chiesi Biotech Center of Excellence opens to strengthen Ry**](https://pharmaphorum.com/news/chiesi-biotech-center-excellence-opens-strengthen-rd-italy) | [[Supply Chain Issues]]; [[Healthcare Operations]]; [[Healthcare]] | | 9/26/2024 | [**The 'patient of the future' is driving radical innovation in healthcare**](https://pharmaphorum.com/patients/future-patient-radical-innovation-healthcare-debiopharm) | [[Healthcare Communications]]; [[Healthcare Costs]]; [[Wearable Health Technology]] | | 9/11/2024 | [**Meet MILTON, AZ's AI that can predict 1,000+ diseases**](https://pharmaphorum.com/news/meet-milton-azs-ai-can-predict-1000-diseases) | [[Ethical Concerns]]; [[Healthcare APIs]]; [[Clinical Care]] | | 9/9/2024 | [**Balancing innovation and safety: The impact of Medtech regulations**](https://pharmaphorum.com/market-access/balancing-innovation-and-safety-impact-medtech-regulations) | [[Healthcare Communications]]; [[Regulatory Landscape]]; [[AI Integration]] | | 9/8/2024 | [**Pharma's use of synthetic biology could deliver radical innovation**](https://pharmaphorum.com/r-d/pharma-synthetic-biology-radical-innovation) | [[AI in Ophthalmology]]; [[AI in Digital Pathology]]; [[Infectious Disease]] | | 9/7/2024 | [**Pfizer: Pharma needs a business strategy for a digital world**](https://pharmaphorum.com/digital/pfizer-pharma-needs-business-strategy-for-digital-world) | [[Employee Engagement]]; [[Smart Healthcare Solutions]]; [[Healthcare Real Estate]] | | 8/31/2024 | [**FH23: Multimodal generative AI and robotics for drug discovery and ageing research**](https://pharmaphorum.com/digital/fh23-multimodal-generative-ai-and-robotics-drug-discovery-and-ageing-research) | [[AI in Pathology]]; [[AI-Driven Predictive Analytics]]; [[AI in Clinical Documentation]] | | 8/28/2024 | [**AI voice assistant can spot complications in heart patients**](https://pharmaphorum.com/news/ai-voice-assistant-can-spot-complications-heart-patients) | [[Pharma]]; [[Clinical AI]]; [[Digital Health Innovation]] | | 8/24/2024 | [**How AI, blockchain, and big data can reduce drug development costs**](https://pharmaphorum.com/views-and-analysis/ai-blockchain-big-data-can-reduce-drug-development-costs) | [[Operational Efficiency]]; [[Product Development]]; [[Healthcare Communication]] | | 8/22/2024 | [**US insomniacs have a new prescription DTx option**](https://pharmaphorum.com/news/us-insomniacs-have-new-prescription-dtx-option) | [[Reimbursement Issues]]; [[Reimbursement Policies]]; [[Personalized Health]] | | 8/20/2024 | [**Five healthtech trends to watch in 2024**](https://pharmaphorum.com/digital/five-healthtech-trends-watch-2024) | [[Digital Health Market Growth]]; [[Smart Medical Devices]]; [[Healthcare]] | | 8/18/2024 | [**Pfizer grows digital team with chief AI officer appointment**](https://pharmaphorum.com/news/pfizer-grows-digital-team-chief-ai-officer-appointment) | [[AI-Driven Automation]]; [[Decentralized Clinical Trials]]; [[Healthcare APIs]] | | 8/15/2024 | [**AI chatbots struggle to interpret patient descriptions**](https://pharmaphorum.com/news/ai-chatbots-struggle-interpret-patient-descriptions) | [[Patient Care]]; [[Personal Care]]; [[Laboratory Genetics]] | | 8/15/2024 | [**NHS telemedicine ambitions approach a pivotal point**](https://pharmaphorum.com/views-analysis-digital/nhs-telemedicine-ambitions-approach-a-pivotal-point) | [[Digital Transformation]]; [[Telemedicine]]; [[Patient Care]] | | 8/14/2024 | [**Otsuka, Click's depression DTx launches in the US**](https://pharmaphorum.com/news/otsuka-clicks-depression-dtx-launches-us) | [[Reimbursement Issues]]; [[Digital Therapeutics]]; [[Reimbursement Rates]] | | 8/12/2024 | [**Increasing patient engagement with UK clinical trials**](https://pharmaphorum.com/webinars/uk-regulatory-pathway-patient-engagement-trials) | [[Regulatory Hurdles]]; [[Contract Compliance]]; [[Digital Engagement]] | | 8/9/2024 | [**EDI in clinical research: The case for adaptive strategies at every step**](https://pharmaphorum.com/rd/edi-clinical-research-case-adaptive-strategies-every-step) | [[Health Equity Initiatives]]; [[Engagement]]; [[Regulatory Landscape]] | | 7/5/2024 | [**Labour, the NHS, and life sciences: Partnerships and people**](https://pharmaphorum.com/patients/labour-nhs-and-life-sciences-partnerships-and-people) | [[Training]]; [[AWS]]; [[Healthcare Interoperability]] | | 7/3/2024 | [**Transforming clinical data management systems for biotechnology trials**](https://pharmaphorum.com/rd/transforming-clinical-data-management-systems-biotechnology-trials) | [[Integration of New Technologies]]; [[Data Management]]; [[Digital Twin Technology]] | | 6/24/2024 | [**Generative AI in clinical trials: Practical use cases and common concerns**](https://pharmaphorum.com/rd/generative-ai-clinical-trials-practical-use-cases-and-common-concerns) | [[AI in Digital Pathology]]; [[AI-Powered Diagnostic Tools]]; [[Federated Data Governance]] | | 6/23/2024 | [**Digital twins in healthcare and drug discovery: From idea to success stories**](https://pharmaphorum.com/digital/digital-twins-healthcare-and-drug-discovery-idea-success-stories) | [[Healthcare Real Estate]]; [[AI in Diagnostics]]; [[Healthcare Communications]] | | 6/19/2024 | [**Maternity care needs improvement, healthtech can help**](https://pharmaphorum.com/digital/maternity-care-needs-improvement-healthtech-can-help) | [[Cybersecurity in Healthcare]]; [[Healthcare Accessibility]]; [[Digital Health Innovations]] | | 6/17/2024 | [**Could Amazon or Google hold the key to the future of public health diagnostics?**](https://pharmaphorum.com/rd/could-amazon-or-google-hold-key-future-public-health-diagnostics) | [[Point-of-Care Diagnostics]]; [[Regulatory Frameworks]]; [[Digital Therapeutics]] | | 6/10/2024 | [**What can pharma companies do to quicken the pace of digital disruption?**](https://pharmaphorum.com/digital/what-can-pharma-companies-do-quicken-pace-digital-disruption) | [[Budget Management]]; [[Emerging Technologies]]; [[Compliance]] | ## Recent Stories (Some LLM-derived content — please confirm with above primary sources) ### Topics Covered - **Disease Spotlights**: Focus on conditions like diabetes, cancer, and rare diseases. - **Pharmaceutical Companies**: Insights into major companies such as Pfizer, Roche, AstraZeneca, and Merck. - **Event Coverage**: Coverage from significant conferences like ASCO and ESMO. - **Medical Affairs and Marketing Strategies**: Importance of digital and social media in engaging healthcare professionals. - **Emerging Trends**: Focus on startups, innovations, sustainability, and the future of generics and AI in pharma marketing. - **Market Access**: Strategies for understanding healthcare professionals and market dynamics. - **Impact of Brexit**: Effects on the pharmaceutical landscape. - **Pharmaceutical Industry Insights**: Coverage of various topics including disease spotlights, medical affairs, market access, and the impact of digital and social media. - **Major Conferences**: Event coverage and insights from significant conferences such as ASCO and ESMO, focusing on advancements in oncology. - **Top Pharmaceutical Companies**: Insights into the operations and contributions of leading companies like Pfizer, Roche, AstraZeneca, and Bristol-Myers Squibb. - **Educational Resources**: Availability of webinars, podcasts, and whitepapers aimed at educating healthcare professionals. - **Medical Affairs and Marketing**: Importance of medical affairs, market access, and digital marketing strategies. - **Sustainability and Brexit**: Discussions on sustainability efforts and the impact of Brexit on the pharmaceutical landscape. - **Knowledge Sharing**: Resources like whitepapers, roundtable discussions, and multimedia content aimed at professionals. - **Pharmaceutical Industry Coverage**: The content includes articles, podcasts, webinars, and event coverage from major conferences like ASCO and ESMO, focusing on various categories such as medical affairs, sales and marketing, rare diseases, and digital media. - **Digital Therapeutics**: The launch of Rejoyn, an FDA-approved digital therapeutic app for managing major depressive disorder, and SleepioRx, a digital cognitive and behavioral therapy program for chronic insomnia. ### Organizations Mentioned - **Pfizer**: A leading global pharmaceutical company known for its research and development of medications. - **Roche**: A Swiss multinational healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. - **AstraZeneca**: A British-Swedish multinational pharmaceutical and biotechnology company. - **Merck**: An American multinational pharmaceutical company known for its contributions to healthcare. - **Bristol-Myers Squibb**: An American pharmaceutical company focused on discovering, developing, and delivering innovative medicines. - **Gilead**: A biopharmaceutical company that discovers, develops, and commercializes innovative medicines. - **Novartis**: A global healthcare company that provides solutions to address the evolving needs of patients worldwide. - **ESMO**: European Society for Medical Oncology, a professional organization for medical oncology. - **ASCO**: American Society of Clinical Oncology, a professional organization for physicians and oncology professionals.